SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 121 filers reported holding SERES THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,630,000 | -75.6% | 475,121 | -49.5% | 0.01% | -71.1% |
Q1 2022 | $6,694,000 | -37.7% | 940,131 | -27.1% | 0.04% | -37.5% |
Q4 2021 | $10,748,000 | +1563.8% | 1,290,297 | +5554.0% | 0.07% | +928.6% |
Q3 2020 | $646,000 | -42.3% | 22,821 | -90.3% | 0.01% | -41.7% |
Q2 2020 | $1,120,000 | +47.8% | 235,307 | +10.8% | 0.01% | +20.0% |
Q1 2020 | $758,000 | -34.1% | 212,379 | -36.3% | 0.01% | -9.1% |
Q4 2019 | $1,150,000 | +82.5% | 333,396 | +112.2% | 0.01% | +37.5% |
Q3 2019 | $630,000 | +170.4% | 157,133 | +117.4% | 0.01% | +166.7% |
Q2 2019 | $233,000 | -82.7% | 72,280 | -63.2% | 0.00% | -84.2% |
Q1 2019 | $1,349,000 | +113.1% | 196,383 | +40.2% | 0.02% | +72.7% |
Q4 2018 | $633,000 | -36.0% | 140,083 | +7.5% | 0.01% | -21.4% |
Q3 2018 | $989,000 | -17.6% | 130,283 | -6.6% | 0.01% | -26.3% |
Q2 2018 | $1,200,000 | +84.3% | 139,484 | +57.3% | 0.02% | +72.7% |
Q1 2018 | $651,000 | -28.1% | 88,684 | -0.6% | 0.01% | -31.2% |
Q4 2017 | $905,000 | – | 89,218 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
Knott David M Jr | 470,000 | $2,251 | 0.90% |
GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |